Suppr超能文献

p53、Ki-67以及基质金属蛋白酶MMP-2和MMP-9在肾盂及输尿管移行细胞癌中的预后价值

The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.

作者信息

Kamijima Shuichi, Tobe Toyofusa, Suyama Takahito, Ueda Takeshi, Igarashi Tatsuo, Ichikawa Tomohiko, Ito Haruo

机构信息

Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.

出版信息

Int J Urol. 2005 Nov;12(11):941-7. doi: 10.1111/j.1442-2042.2005.01159.x.

Abstract

AIM

To investigate the prognostic and predictive relevance of p53 protein, Ki-67 antigen, MMP-2 and MMP-9 in patients with transitional cell carcinoma (TCC) of the upper urinary tract.

METHODS

The expression of p53 protein, Ki-67 antigen, MMP-2 and MMP-9 was examined by immunohistochemistry in 69 patients with TCC of the upper urinary tract. Correlation of p53, Ki-67, MMP-2 and MMP-9 over-expression with conventional pathological parameters and patient survival was examined.

RESULTS

p53 over-expression was significantly correlated with histological grade (P < 0.05), but not with pathological stage, vascular invasion, lymphatic invasion or lymph node metastasis. Ki-67 over-expression was significantly correlated with stage, grade, lymphatic invasion and vascular invasion (P < 0.05). In survival analyses, Ki-67 over-expression was a significant prognostic factor in the univariate analysis (P < 0.05), but it did not have a significant impact on survival in the multivariate analysis. Ki-67 labeling index was a significant prognostic factor in patients with a low p53 labeling index, but not in patients with a high p53 labeling index.

CONCLUSION

Ki-67 over-expression is of prognostic value in TCC of the upper urinary tract, while p53, MMP-2 and MMP-9 are of limited value.

摘要

目的

探讨p53蛋白、Ki-67抗原、基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)在上尿路移行细胞癌(TCC)患者中的预后及预测相关性。

方法

采用免疫组织化学法检测69例上尿路TCC患者中p53蛋白、Ki-67抗原、MMP-2和MMP-9的表达。检测p53、Ki-67、MMP-2和MMP-9过表达与传统病理参数及患者生存率的相关性。

结果

p53过表达与组织学分级显著相关(P<0.05),但与病理分期、血管侵犯、淋巴侵犯或淋巴结转移无关。Ki-67过表达与分期、分级、淋巴侵犯和血管侵犯显著相关(P<0.05)。在生存分析中,Ki-67过表达在单因素分析中是一个显著的预后因素(P<0.05),但在多因素分析中对生存无显著影响。Ki-67标记指数在p53标记指数低的患者中是一个显著的预后因素,但在p53标记指数高的患者中不是。

结论

Ki-67过表达在上尿路TCC中具有预后价值,而p53、MMP-2和MMP-9价值有限。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验